Flucloxacillin 500 mg powder for solution for injection/infusion
Authorisation PA1122/036/001 · Noridem Enterprises Limited
- Licence holder
- Noridem Enterprises Limited (all products →)
- Active substance
- Flucloxacillin sodium monohydrate
- Dosage form
- Powder for solution for injection/infusion
- Routes of administration
- Intramuscular use, Intravenous use
- ATC code
- J01CF05
- First authorised
- 15/11/2024
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Generic application (Article 10(1) of Directive No 2001/83/EC)
Flucloxacillin sodium monohydrate: supply and approvals
32 authorised products on the HPRA list contain Flucloxacillin sodium monohydrate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 21 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 21 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 21 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 2 years (since 15 November 2024). The HPRA list marks it as not marketed: it is licensed but the holder has not reported it as on sale.
Other medicines with Flucloxacillin sodium monohydrate in Ireland
5 other products on the HPRA list contain Flucloxacillin sodium monohydrate, from 2 licence holders; 0 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Flucloxacillin 1000 mg powder for solution for injection/infusion | Noridem Enterprises Limited | National authorisation (PA) | Not marketed |
| Flucloxacillin 1g Powder for Solution for Injection or Infusion | Pinewood Laboratories Limited | National authorisation (PA) | Not marketed |
| Flucloxacillin 2000 mg powder for solution for injection/infusion | Noridem Enterprises Limited | National authorisation (PA) | Not marketed |
| Flucloxacillin 250mg Powder for Solution for Injection or Infusion | Pinewood Laboratories Limited | National authorisation (PA) | Not marketed |
| Flucloxacillin 500mg Powder for Solution for Injection or Infusion | Pinewood Laboratories Limited | National authorisation (PA) | Not marketed |
The licence holder
Noridem Enterprises Limited holds 70 products on the HPRA list, with 55 different active substances; 21 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.